Oncocine is engineering the future of cancer treatment; transforming each patient's unique cancer signature into a precision mRNA vaccine
Oncocine is engineering the future of cancer treatment; transforming each patient's unique cancer signature into a precision mRNA vaccine. Our ONVAC platform harnesses AI-driven multi-omics modelling to decode the complex interplay between tumour mutations and immune responses, delivering fully optimised cancer vaccine candidates in a fraction of traditional timelines.